Xu et al. (2021) demonstrated that crocetin mitigated hepatic inflammation and lipid accumulation in NAFLD models by enhancing antioxidant defenses and modulating the Nrf2/HO-1 pathway [56]. The gene discussed is HMOX1; the disease is metabolic dysfunction-associated steatotic liver disease.